Every recall we track for Johnson Matthey Inc. — 5 in all, from 2018–2019 — plus the complaints and injury reports the public filed about them.
Recalls on record by year — 5 drug.
Johnson Matthey recalls Fentanyl Citrate Active Pharmaceutical Ingredient due to potential glass contamination from cGMP deviations. Affected lots expire Feb 2023.
Johnson Matthey recalls Remifentanil HCl active pharmaceutical ingredient due to unknown impurities exceeding safety limits. This API is used in manufacturing and repackaging. No remedy specified in official notice.
Johnson Matthey recalls Morphine Sulfate USP Milled API due to microbial contamination. This active pharmaceutical ingredient is used in prescription pain management. Consumers should contact the manufacturer for details.
5 recalls from Johnson Matthey Inc. are on record with U.S. safety agencies, from 2018–2019.
Johnson Matthey Inc. recalls Fentanyl Citrate Active Pharmaceutical Ingredient, Johnson Matthey Pharmaceutical Materials 2003 Nolte Drive, West, dated Aug 29, 2019. Every Johnson Matthey Inc. recall is listed on this page, newest first.
The most common reasons on record: cGMP Deviations: Potential glass contamination (3).
Match the NDC and lot number on your bottle or box to the recall. Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first. Report side effects to FDA MedWatch.
Sign up for free email alerts on GovInfoNow — we check official CPSC, FDA, USDA and NHTSA data every day and email you only when a recall matches what you follow.
